FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns anthracycline conjugates with carriers, such as antibodies; methods for preparing them; a pharmaceutical composition containing them; and to using them in treating tumours in mammals.
EFFECT: group of inventions provides the high and selective effect of tumour cell destruction.
36 cl, 12 ex, 32 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES WITH CYSTEINE SUBSTITUITIONS AND THEIR CONJUGATES PRODUCED BY GENE ENGINEERING | 2011 |
|
RU2626537C2 |
| CONJUGATES OF ANTIBODIES AND DRUGS CHARACTERIZED IN HIGH IN VIVO TOLERANCE | 2018 |
|
RU2764031C2 |
| ANTIBODIES WITH CYSTEINE SUBSTITUTIONS OBTAINED BY GENETIC ENGINEERING AND THEIR CONJUGATES | 2011 |
|
RU2755066C2 |
| PEPTIDOMIMETIC COMPOUNDS AND THEIR CONJUGATES OF ANTIBODIES WITH DRUGS | 2014 |
|
RU2689388C1 |
| ANTIBODY-DRUG CONJUGATES AND METHODS OF USING SAID CONJUGATES OF PYRROLOBENZODIAZEPINE | 2016 |
|
RU2736725C1 |
| ANTIBODIES AND IMMUNOCONJUGATES AND THEIR APPLICATION | 2007 |
|
RU2436796C9 |
| ANTHRACYCLINE-ANTIBODY CONJUGATES | 2004 |
|
RU2349343C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2009 |
|
RU2553566C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2008 |
|
RU2511410C2 |
| MULTISPECIFIC ANTIBODIES, THEREOF ANALOGUES, COMPOSITIONS AND METHODS | 2010 |
|
RU2580038C2 |
